scholarly journals False-Positive Serology for Hepatitis B After Intravenous Immunoglobulin Therapy for Toxic Epidermal Necrolysis

2021 ◽  
Author(s):  
A. Sánchez-Herrero ◽  
L.M. Nieto-Benito ◽  
A.M. Rosell-Díaz ◽  
A. Pulido-Pérez
Keyword(s):  
Hepatitis B ◽  
Toxic Epidermal Necrolysis ◽  
Intravenous Immunoglobulin ◽  
False Positive ◽  
Immunoglobulin Therapy ◽  
Positive Serology ◽  
Intravenous Immunoglobulin Therapy

scholarly journals Assessing Hepatitis B Reactivation Risk With Rituximab and Recent Intravenous Immunoglobulin Therapy

2020 ◽  
Vol 7 (3) ◽  
Author(s):  
Claire Dysart ◽  
Karine Rozenberg-Ben-Dror ◽  
Mariscelle Sales
Keyword(s):  
Hepatitis B ◽  
Intravenous Immunoglobulin ◽  
Inappropriate Prescribing ◽  
Immunoglobulin Therapy ◽  
Morbidity And Mortality ◽  
Significant Morbidity ◽  
Intravenous Immunoglobulin Therapy ◽  
Hepatitis B Reactivation ◽  
False Positivity

Abstract Hepatitis B reactivation (HBR) is a complication of immunosuppression associated with significant morbidity and mortality. To further complicate interpretation of hepatitis B serologies, false positivity can occur in patients with recent intravenous immunoglobulin exposure. This scenario is not well recognized and may lead to inappropriate prescribing of HBR prophylaxis.

Efficacy of Intravenous Immunoglobulin Therapy in Childhood Atopic Dermatitis

2012 ◽  
Vol 18 (1) ◽  
pp. 26-31
Author(s):  
Eun Kyeong Yeon ◽  
A Young Park ◽  
Sanghoon Chae ◽  
Seung Soo Kim ◽  
Kyeong Bae Park ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Intravenous Immunoglobulin ◽  
Immunoglobulin Therapy ◽  
Intravenous Immunoglobulin Therapy
Sign in / Sign up

Export Citation Format

Share Document